Zydus Lifesciences gets zero USFDA observations for Ahmedabad facility Ruchika Sharma14 Jun 2023 12:30 PM ISTAhmedabad: Zydus Lifesciences Ltd. has announced that the United States Food and Drug Administration (USFDA) has concluded...
USFDA approves Zydus Varenicline Tablets for smoking addiction treatment Ruchika Sharma13 Jun 2023 5:30 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug Administration ...
Zydus Lifesciences wins USFDA nod for Diclofenac Sodium and Misoprostol Delayed Release Tablets Ruchika Sharma13 Jun 2023 4:12 PM ISTDiclofenac Sodium and Misoprostol Delayed Release Tablets are used to treat osteoarthritis and rheumatoid arthritis in people at high risk for...
Zydus gets USFDA nod for bowel disease drug Balsalazide Disodium Ruchika Sharma10 Jun 2023 3:17 PM ISTThe product will be manufactured at the group’s formulation manufacturing facility in SEZ, Ahmedabad, India.
Zydus Lifesciences begins Phase IV trial for fatty liver disease drug Saroglitazar Magnesium Ruchika Sharma9 Jun 2023 12:30 PM ISTThe USFDA has granted Fast Track status and Orphan Drug Designation for Saroglitazar Mg in PBC.
Zydus Lifesciences secures USFDA okay for Esomeprazole Magnesium for Delayed-Release Oral Suspension Ruchika Sharma8 Jun 2023 2:51 PM ISTEsomeprazole belongs to a class of drugs known as proton pump inhibitors.
Zydus Lifesciences bags USFDA nod for pulmonary arterial hypertension drug Tadalafil Ruchika Sharma8 Jun 2023 11:32 AM ISTThe product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, India.
Bayer faces shortage of contraceptive pill Yasmin in India Ruchika Sharma7 Jun 2023 4:30 PM ISTThe drugstore operators that Reuters spoke with said they were unaware of the reason for the shortage, nor when the pill would be available next.
Zydus gets zero USFDA observations for Ahmedabad animal health drug manufacturing facility Ruchika Sharma3 Jun 2023 11:52 AM ISTAhmedabad: Through a recent BSE filing, Zydus Lifesciences Ltd. has informed that the US Food and Drug Administration (USFDA) has concluded the...
Zydus Lifesciences reports 25 percent decline in consolidated net profit at Rs 297 crore in Q4 Ruchika Sharma20 May 2023 10:00 AM ISTNew Delhi: Zydus Lifesciences Ltd on Thursday reported a 25.36 per cent decline in consolidated net profit at Rs 296.6 crore in the fourth quarter...
Zydus Lifesciences bags USFDA nod for hypotension injection Ephedrine Sulfate Ruchika Sharma17 May 2023 12:13 PM ISTThe drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara, India.
Zydus Lifesciences Moraiya facility gets EIR from USFDA Ruchika Sharma11 May 2023 11:35 AM ISTThe inspection was a PAI for Transdermal Patch products
